North America POCT Market to Showcase Sustainable Growth, Predicts Data Bridge in Its Cutting-Edge Report Available at MarketPublishers.com
28 Nov 2017 • by Natalie Aster
LONDON – In North America, the point-of-care testing (POCT) market is driven by multiple factors, such as the increased chronic diseases’ incidence, the rising geriatric population, and advancements in the technology fields. Staff shortages cited by North American laboratories are one more important driving force.
Yet, this market faces certain restraints, and the economic cost and the unfavorable reimbursement scenarios count among major ones.
Emerging markets and unmet medical needs create favorable environment that encourages the market growth. As the result, the local marketplace is forecast to see sustainable growth at an 8% CAGR over the period 2017-2024. It is estimated to surpass the USD 17,800 million mark by 2024.
F. Hoffmann-La Roche, Abbott Laboratories, and Siemens are top players active in the region.
Cutting-edge research study “North America POCT Market Analysis” drawn up by Data Bridge Market Research provides a careful look at the North America POCT marketplace. The report offers an in-depth overview of this market. It casts light on driving factors and restraints, besides discussing opportunities and challenges of the marketplace.
The study casts light on regulatory and reimbursement scenarios. The research report thoroughly investigates the marketplace on the basis of product types and distribution channels. It scrutinizes the local space on the basis of end-users and prescription modes.
The research study explores the market performance across the U.S., Canada, and Mexico. The company landscape is also touched upon in the report. Top companies’ profiles are also on hand in this detailed study.
More insightful reports by the publisher are available at its page.